NMC Health PLC (LON:NMC) Rating Reaffirmed
In an analyst research report published on 18 December, The “Buy” rating of NMC Health PLC (LON:NMC) shares was has decided to restate by Jefferies International, who now has a GBX 1350.00 target price per share on the stock. Jefferies International’s target price per share gives a possible upside of 50.25% from the closing share price of the company.
From a total of 10 analysts covering NMC Health PLC (LON:NMC) stock, 8 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that 100% of the ratings are positive. The highest target price is GBX 18.98 while the lowest target price is GBX 13.36. The mean of all analyst targets is GBX 15.72 with a 19.37% above today’s (GBX 898.5) stock price. NMC Health PLC was the topic of 5 analyst reports since August 26, 2015 according to the firm StockzIntelligence Inc. Investec maintained shares on November 27 with “Buy” rating.
The stock increased 1.76% or GBX 15.5 on December 17, striking GBX 898.5. Approximately 25,839 shares of stock traded hands. NMC Health PLC (LON:NMC) has risen 8.19% since May 21, 2015 and is uptrending. It has outperformed by 10.45% the S&P500.
NMC Health plc is a healthcare operator in the United Arab Emirates. The company has a market cap of 1.71 billion GBP. The Company, through its subsidiaries, is engaged in providing professional medical services, wholesale of pharmaceutical goods, medical equipment, cosmetics, food and IT services and products in the United Arab Emirates. It has 33.11 P/E ratio. It operates through two divisions: healthcare segment and distribution and services segment.